Armata Pharmaceuticals (ARMP) Preferred Dividend Payments (2013 - 2016)
Armata Pharmaceuticals' (ARMP) quarterly Preferred Dividend Payments came in at $133000.0 in Q2 2016, down 92.72% year-over-year from $1.8 million in Q3 2015, and down 92.29% quarter-over-quarter from $1.7 million in Q1 2016.
Analysis
Armata Pharmaceuticals (ARMP) Preferred Dividend Payments (2013 - 2016) Analysis & Trends
Armata Pharmaceuticals has disclosed Preferred Dividend Payments across 4 years of filings, most recently posting $133000.0 for Q2 2016.
- In Q2 2016, Preferred Dividend Payments fell 92.72% year-over-year to $133000.0; the TTM figure through Dec 2016 stood at $1.9 million (down 81.92% YoY), while the FY2016 annual figure was $1.9 million, down 81.92% from the prior year.
- Preferred Dividend Payments came in at $133000.0 for Q2 2016 at Armata Pharmaceuticals, down from $1.7 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $7.2 million in Q3 2015 to a low of $103000.0 in Q2 2013.
- Average Preferred Dividend Payments over 4 years is $1.1 million, with a median of $323000.0 recorded in 2014.
- Year-over-year, Preferred Dividend Payments jumped 2117.65% in 2015 and plunged 92.72% in 2016.
- Over 4 years, Preferred Dividend Payments stood at $229000.0 in 2013, then jumped by 44.1% to $330000.0 in 2014, then jumped by 187.58% to $949000.0 in 2015, then slumped by 85.99% to $133000.0 in 2016.
- Per Business Quant data, the three most recent Preferred Dividend Payments figures were $133000.0 in Q2 2016, $1.7 million in Q1 2016, and $949000.0 in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Armata Pharmaceuticals | 203.22 Mn | 179.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 133,000.00 |
| Mar 31, 2016 | 1.73 Mn |
| Dec 31, 2015 | 949,000.00 |
| Sep 30, 2015 | 7.16 Mn |
| Jun 30, 2015 | 1.83 Mn |
| Mar 31, 2015 | 338,000.00 |
| Dec 31, 2014 | 330,000.00 |
| Sep 30, 2014 | 323,000.00 |
| Jun 30, 2014 | 318,000.00 |
| Mar 31, 2014 | 314,000.00 |
| Dec 31, 2013 | 229,000.00 |
| Sep 30, 2013 | 286,000.00 |
| Jun 30, 2013 | 103,000.00 |